Skip to content

ULTIPAQ FSR100208-20Recalls & reported problems

Medos International Sàrl · ULTIPAQ microcoil ULTIPAQ 10 Stretch Resistant Coil 2mm x 8cm 190cm Contents: 1 Detachable Coil System · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00878528001553), received between Oct 13, 2017 and Oct 13, 2017 — classified as 1 malfunction.

The most frequently reported specific device problem is “Physical Resistance” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Physical Resistance1
  • Stretched1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 13, 2017Stretched; Physical Resistance; Stretched; Physical Resistance

    AS REPORTED BY A HEALTHCARE PROFESSIONAL, DURING COIL EMBOLIZATION AT AN UNKNOWN LOCATION, AN ULTIPAQ COIL (FSR10020820/ S10351) COULD NOT BE PLACED INTO THE ENTRANCE OF AN UNSPECIFIED CATHETER AND DURING PRODUCT ANALYSIS, IT WAS DETERMINED THAT THE COIL WAS STRETCHED. THE SAME TYPE COIL ADVANCED THROUGH THE SAME CATHETER AFTERWARD. THERE WAS NO POTENTIAL ADVERSE EVENT TO THE PATIENT AND THE PROCEDURE WAS DELAY 5 MINUTES.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6947548 ↗

Other DEVICE, NEUROVASCULAR EMBOLIZATION devices

All DEVICE, NEUROVASCULAR EMBOLIZATION devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page